Corporate Members

Merck

About Us: For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world. During this unprecedented time, Merck is committed to ensuring our medicines and vaccines reach our patients and customers. This includes supporting patients who might need more help today with their medications, including those who may have lost insurance coverage, or may not be able to afford their medication due to the COVID-19 pandemic. To learn about what support options may be available to eligible patients visit our Access and Patient Assistance information page. For more details about Merck’s response to coronavirus, visit our COVID-19 information page. This content is intended for health care professionals of the United States, its territories, and Puerto Rico.

Website:
https://www.merck.com/

Johnson & Johnson (Janssen)

About Us: At Janssen, we’re creating a future where disease is a thing of the past.  We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.  At Janssen, we’re shaping the future of treatment.  And in the process, we’re striving to change expectations of what a cancer diagnosis means.  Our purpose is driven by an urgency and commitment to bringing transformational solutions to the people who need them.  For more information, visit https://www.janssen.com/oncology. For more information about Johnson & Johnson’s response to the COVID-19 outbreak, please visit https://www.jnj.com/coronavirus.

Websites:
https://www.janssen.com/oncology
https://www.janssen.com/products/Oncology

Social Media:
Twitter: https://www.twitter.com/janssenoncus
LinkedIn: https://www.linkedin.com/company/janssen-pharmaceutical-companies-of-johnson-and-johnson/

5K Members

Astellas

Bayer

Bristol Myers Squibb

About Us: At Bristol Myers Squibb, we work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.  We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms. We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. We aspire to be at the center of a vibrant healthcare innovation ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.  During this unprecedented time, if you have U.S. patients who have lost jobs and health insurance due to COVID-19, we will o­ffer our covered medicines at no cost. For a complete list of our covered medicines, patients can call 1-800-721-8909 or visit www.bms.com to learn more.

Website:
www.bms.com

Representative Contacts: 
Patrick Curtin, Patrick.Curtin@bms.com, 908-420-7093

Natera

About Us: Natera has developed Signatera, a personalized ctDNA test for molecular residual disease (MRD) detection and recurrence monitoring in patients previously diagnosed with cancer. Signatera's tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence with longer lead times. The test is available for clinical and research use, and has been designated by the FDA as a Breakthrough Device. Signatera has also received Medicare draft coverage for Stage II-III colorectal cancer. Signatera has been clinically validated in multiple cancer types including colorectal, non-small cell lung, breast, and bladder cancers. Look deeper at natera.com/oncology    

Website:
natera.com/oncology 

Representative Contacts: 
Lisa Roman, lroman@natera.com, 650-464-7074;
Lydia Hammond, lhammond@natera.com, 507-261-9537

Social Media:
Twitter:  https://twitter.com/NateraOncology    
LinkedIn:  https://www.linkedin.com/company/natera/    
Facebook:  https://www.facebook.com/NateraGenetics/

Pfizer

About Us: At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer.

At Pfizer Oncology Together, patient support is at the core of everything we do. From helping to identify financial assistance options to connecting patients to resources for emotional support, the needs of patients prescribed Pfizer Oncology medications are our priority.

Website:
www.PfizerOncologyTogether.com/HCP

Sanofi Genzyme

About Us: Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.

Website:
www.sanofigenzyme.com

Representative Contacts:
Nanette Rutherford, Field Reimbursement Manager, Nanette.rutherford@sanofi.com, 724-708-6495

Social Media: 
Twitter: https://twitter.com/SanofiGenzyme
LinkedIn https://www.linkedin.com/company/sanofigenzyme/
Facebook: https://www.facebook.com/SanofiGenzyme/